NYSEAMERICAN:PFNX - Pfenex Inc.
$4.19
 $0.12
+2.95%
4:20PM EDT
2019-02-22
Pfenex Inc., incorporated on November 19, 2009, is a clinical-stage biotechnology company. The Company is engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and other high-value and difficult-to-manufacture proteins. The Company's lead product candidate is PF582, a biosimilar candidate to Lucentis (ranibizumab). The Company's next advanced product candidates are PF530 and PF708. PF530 is a biosimilar candidate to Betaseron (interferon beta-1b). PF708 is being developed as a therapeutically equivalent peptide to Forteo (teriparatide), which is for the treatment of osteoporosis. In addition to its three advanced product candidates, its pipeline includes over four other biosimilar candidates, as well as vaccines and next generation biologic candidates. Its product candidates are enabled by its protein production platform, Pfenex Expression Technology.The Company's pipeline of product candidates and preclinical products under development include over four owned programs, one that is being developed in collaboration with Pfizer, Inc. and over three that are being developed in a joint venture with Strides Arcolab Limited, a specialty pharmaceutical company. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  PFNX     avg for
industry  
  avg for
sector  
42 stocks weight:  18. 56   0. 00   0. 00  
42 stocks rank:  3. 65 K 2. 00 K 1. 08 K
# analyst opinions:  1. 00   14. 68   14. 18  

quick ratio:  3. 60   5. 17   1. 75  
current ratio:  3. 71   5. 48   2. 10  

target price low:  4. 14   90. 05   118. 16  
target price avg:  4. 14   115. 98   142. 03  
target price high:  4. 14   141. 44   162. 86  
1-yr high:  8. 80   124. 28   143. 16  
last close:  4. 20   102. 75   129. 63  
50-day avg:  3. 82   98. 90   122. 76  
200-day avg:  4. 78   100. 04   123. 17  
1-yr low:  3. 19   78. 22   100. 14  
volume:  59. 59 K 2. 36 M 4. 94 M
50-day avg volume:  65. 71 K 3. 14 M 4. 85 M
200-day avg volume:  140. 84 K 3. 12 M 4. 26 M

1-day return:  2. 94 % 1. 74 % 0. 96 %
this week return:  4. 22 % -0. 72 % -0. 25 %
12-wk return:  1. 45 % 1. 23 % -0. 75 %
52-wk return:  17. 21 % -2. 03 % 16. 23 %

enterprise value (EV):  62. 70 M 54. 82 B 107. 48 B
market cap:  132. 13 M 47. 12 B 97. 54 B
EBITDA:  -25. 97 M 4. 72 B 7. 18 B
enterprise multiple (EV/EBITDA):  -2. 41   9. 03   16. 84  
enterprise/revenue (EV/R):  2. 13   31. 24   24. 21  
total revenue:  29. 41 M 11. 05 B 40. 03 B
total debt:  589. 00 K 13. 41 B 16. 70 B
debt/equity:  0. 88   41. 61   80. 63  
net income (common):  -27. 28 M 2. 34 B 3. 61 B

shares outstanding:  31. 46 M 594. 48 M 1. 22 B
shares:  30. 77 M 592. 96 M 1. 15 B
shares short:  690. 96 K 10. 54 M 11. 92 M
shares short prior month:  694. 48 K 11. 90 M 11. 87 M
short ratio:  11. 82   4. 86   3. 18  
short % of float:  3. 89 % 6. 23 % 2. 78 %
total cash/share:  2. 16   11. 99   10. 04  
total cash:  67. 83 M 7. 30 B 7. 05 B
free cash flow:  -10. 20 M 176. 15 M 2. 43 B
operating cash flow:  -18. 64 M 277. 94 M 3. 06 B

book value:  2. 14   15. 06   28. 80  
price/book:  1. 96   -0. 58   -2. 51  
gross profits:  23. 62 M 8. 33 B 19. 31 B
operating margins:  -93. 87 % -466. 96 % -635. 17 %
EBITDA margins:  -88. 30 % 13. 54 % 22. 51 %
profit margins:  -92. 74 % 6. 67 % 10. 02 %
gross margins:  80. 97 % 48. 21 % 54. 28 %

1-yr max volatility:  31. 15 % --- ---
1-yr mean volatility:  0. 21 % 0. 01 % 0. 07 %

1-yr EPS:  -1. 03   3. 08   4. 11  
forward EPS:  -1. 15   4. 75   7. 18  
P/E:  -4. 06   15. 54   29. 27  
forward P/E:  -3. 55   -20. 90   3. 33  
PE/G:  0. 14   1. 33   6. 07  
growth:  -28. 90 % 755. 42 % 114. 65 %
earnings high:  -0. 31   1. 33   1. 68  
earnings avg:  -0. 35   0. 97   1. 54  
earnings low:  -0. 39   0. 70   1. 41  
revenue high:  6. 30 M 2. 81 B 11. 37 B
revenue avg:  4. 40 M 2. 70 B 11. 06 B
revenue low:  2. 50 M 2. 61 B 10. 84 B
return on assets:  -21. 35 % -3. 63 % 3. 73 %
return on equity:  -45. 86 % 102. 34 % 26. 90 %
revenue growth:  -28. 90 % 717. 29 % 107. 00 %
revenue/share:  1. 12   14. 67   60. 08  

beta (1yr vs S&P500):  0. 63   1. 22   0. 94  
sharpe (1yr):  0. 66   0. 14   1. 05  

held % insiders:  2. 14 % 6. 40 % 3. 16 %
held % institutions:  81. 44 % 79. 62 % 70. 81 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-22 : PFNX
.    + 1.014 =         1.014 :: INITIAL WEIGHT
.  + 538.801 =       539.815 :: inverse volume-to-price addition
.    + 0.038 =       539.854 :: spline projection addition
.  - 165.464 =        374.39 :: poor performance penalty
.      x 1.2 =       449.268 :: one-year gains+dividend factor
.    x 7.764 =      3488.291 :: 13 weeks' performance factor
.    x 1.478 =      5155.498 :: industry recommendation factor
.    x 1.068 =      5507.178 :: EV/R factor
.    x 0.998 =       5495.42 :: return on assets factor
.    x 0.995 =      5470.217 :: return on equity factor
.    x 0.997 =      5454.408 :: revenue growth factor
.    x 2.676 =      14596.92 :: current ratio factor
.    x 1.177 =     17179.825 :: quick ratio factor
.    x 1.041 =     17891.799 :: short ratio factor
.     x 2.02 =     36134.745 :: price-to-book factor
.     x 1.01 =     36512.665 :: debt-to-equity factor
.    x 1.066 =     38930.279 :: 5-day avg > 50-day avg
.    x 2.108 =     82047.265 :: P/E weight
.    x 1.634 =    134032.875 :: PE/G factor
.    x 1.514 =     202882.04 :: beta factor
.    x 0.663 =    134534.534 :: sharpe factor
.    x 0.988 =    132900.335 :: target low factor
.    x 0.978 =    130038.976 :: target mean factor
.    x 0.988 =    128459.385 :: target high factor
.    x 1.012 =    130040.972 :: industry 12-weeks return
.    x 0.929 =    120824.417 :: "drift" penalty 3 days ago
.    x 0.997 =    120463.132 :: overall "drift" factor
.    x 0.689 =     82941.826 :: largest single-day jump factor
.    x 0.077 =      6389.971 :: low price factor
.      x 1.0 =      6389.309 :: factor hist industry gain for week 07
.   cubeRoot =        18.556 :: reduced for readability
.                     18.556 :: FINAL WEIGHT for NYSEAMERICAN:PFNX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org